Hostname: page-component-77f85d65b8-8wtlm Total loading time: 0 Render date: 2026-04-12T18:18:51.736Z Has data issue: false hasContentIssue false

Impact of multifaceted clinical decision support and education on antibiotic duration in outpatients with respiratory tract infections in Saudi Arabia: a prospective pre- and postimplementation study

Published online by Cambridge University Press:  17 November 2025

Ahlam Alghamdi*
Affiliation:
Department of Pharmacy Practice, College of Pharmacy, Princess Nourah bint Abdulrahman University, Riyadh, Saudi Arabia
Mohammed Alraey
Affiliation:
Department of Infectious Diseases, King Abdullah bin Abdulaziz University Hospital, Riyadh, Saudi Arabia
Mohammad Aatif Khan
Affiliation:
Microbiology Laboratory, Department of Pathology and Laboratory Medicine, King Abdullah Bin Abdul-Aziz University Hospital, Princess Nourah bint Abdulrahman University, Riyadh, Saudi Arabia
Lina I. Alnajjar
Affiliation:
Department of Pharmacy Practice, College of Pharmacy, Princess Nourah bint Abdulrahman University, Riyadh, Saudi Arabia
Reem Binsuwaidan
Affiliation:
Department of Pharmaceutical Sciences, College of Pharmacy, Princess Nourah bint Abdulrahman University, Riyadh, Saudi Arabia
Maram Almutairi
Affiliation:
Pharmaceutical Care Services, King Abdullah bin Abdulaziz University Hospital, Riyadh, Saudi Arabia
Faridah Alsafi
Affiliation:
Pharmaceutical Care Services, King Abdullah bin Abdulaziz University Hospital, Riyadh, Saudi Arabia
Nouf Alhumaidah
Affiliation:
PharmD Candidate, College of Pharmacy, Princess Nourah bint Abdulrahman University, Riyadh, Saudi Arabia
Hala Alqhatani
Affiliation:
PharmD Candidate, College of Pharmacy, Princess Nourah bint Abdulrahman University, Riyadh, Saudi Arabia
Eman Alghamdi
Affiliation:
Saudi Food and Drug Authority, Riyadh, Saudi Arabia
Wejdan Alassaf
Affiliation:
Emergency Department, King Khalid University Hospital, King saud university Medical city, Riyadh, Saudi Arabia
Abdulaziz Saad Aleissa
Affiliation:
Family Medicine department, King Abdullah bin Abdulaziz University Hospital, Riyadh, Saudi Arabia
*
Corresponding author: Ahlam Alghamdi; Email: ph.ahalghamdi@gmail.com

Abstract

Objectives:

Prolonged antibiotic therapy is associated with an increased risk of antimicrobial resistance and adverse events. We evaluated the implementation of a multifaceted antimicrobial stewardship (ASP) initiative aimed at reducing antibiotic duration for respiratory tract infections (RTIs) in outpatient settings.

Designs:

Quasi-experimental study.

Settings:

Academic medical center in Riyadh, Saudi Arabia.

Patients:

Patient with RTIs in outpatient settings

Methods:

A multifaceted ASP intervention—including a clinical decision support tool and an educational session—was implemented to guide physicians in prescribing the shortest effective duration of oral antibiotics. We compared antibiotic utilization and adherence to evidence-based duration prescribing in a preintervention phase (June 2021–December 2021) and a postintervention phase (January 2022–June 2022) .

Results:

We included 2320 patients in our study, of which 1359 were in the preintervention period and 961 in the postintervention period. Following implementation of the multifaceted stewardship initiative, the days of therapy (DOT) per 1,000 outpatient visits decreased from 131 to 50 and the mean duration of antibiotic therapy declined from 6.4 to 6.0 days (p < 0.001). Adherence to the recommended duration improved, with the percentage of prescriptions meeting recommended duration increasing from 49.7% to 56.3% (p = 0.002).

Discussion:

The multifaceted ASP initiative can reduce unnecessary antibiotic exposure and improve the adherence to the recommended duration.

Information

Type
Original Article
Creative Commons
Creative Common License - CCCreative Common License - BY
This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution and reproduction, provided the original article is properly cited.
Copyright
© The Author(s), 2025. Published by Cambridge University Press on behalf of The Society for Healthcare Epidemiology of America

Introduction

Antimicrobial resistance (AMR) is a critical global health challenge, with international and national efforts actively promoting appropriate antibiotic use to reduce the emergence and spread of resistance. 1Reference Almakrami, Salmen and Aldashel4 In Saudi Arabia, the national AMR Action Plan—guided by the Global AMR Action Plan—promotes the development of antimicrobial stewardship program (ASP), automation, and surveillance. 2,5,6

One of the major contributing factors to the emergence and spread of AMR is the prolonged use of antibiotics. Reference Wald-Dickler and Spellberg7 Multiple randomized trials comparing the short versus long duration of oral antibiotic therapy demonstrated that a shorter duration of antibiotics are as effective as longer duration of antibiotics with fewer adverse events. Reference Wald-Dickler and Spellberg7,Reference Moussaoui, De Borgie and Van Den Broek8

Although ASPs have been widely implemented in Saudi Arabia to ensure antibiotics are prescribed appropriately and reduce the emergence of AMR, there is a notable gap in initiatives focused on optimizing the duration of antimicrobial therapy. Reference Alshehri, Aldali and Abdelhamid9 Therefore, our institutional ASP team sought to assess the impact of multifaceted initiatives including clinical decision support (CDS) and education on antibiotic duration, with a focus on antibiotic utilization and adherence for respiratory tract infections (RTIs) in outpatient settings.

Method

We conducted a quasi-experimental study at an academic medical center with 400 beds in Riyadh, Saudi Arabia. We compared oral antibiotic prescribing using evidence-based duration defaults for RTIs in a preintervention phase (June 2021–December 2021) and a postintervention phase (January 2022–June 2022) without incorporating a washout period in outpatient settings. The implemented antibiotic duration in the EHR, as approved by the institutional ASP committee, includes pediatrics and adults, is shown in Table 1. An RTI order set was implemented in the EHR’s Preferred Orders menu to standardize prescribing. Selecting the RTI diagnosis triggered a list of recommended antibiotics with approved treatment durations aligned with institutional guidelines. Clinicians chose the agent, with the option to modify dose or duration as clinically indicated.

Table 1. Institutional antimicrobial stewardship guidelines on recommended duration of oral antibiotic therapy for respiratory infections in outpatient settings

Strep throat infection duration includes penicillin and other antibiotics.

From the outpatient data set, we extracted all antibiotic prescriptions and analyzed those associated with community-acquired pneumonia (CAP) or upper respiratory tract infection (URTI) and encountered diagnoses in adults and children. We included outpatients on oral antibiotics for CAP or URTI. We excluded patients who received antibiotics for less than 72 hours, those with recurrent sinusitis, complicated acute bacterial sinusitis, other nonrespiratory infections, and immunocompromised individuals.

We assessed the impact of our stewardship initiative through measuring antibiotic utilization and percentage of prescriptions adhering to embedded duration for included patients in outpatient settings. We used days of therapy (DOT) metric to evaluate the antibiotic utilization and percentage of prescriptions adhering to recommended duration to assess compliance.

Calculation Method for Antibiotic Consumption:

  1. 1. Formula: DOT per 1 000 outpatient visits = (Total antibiotic days for RTI/Total outpatient visits) × 1 000

Duration-based antibiotic stewardship intervention

Automation

We implemented the institutional ASP-approved CDS in the EHR for RIT on January 1, 2022. This initiative aims to voluntarily guide physicians to choose the shortest effective duration of antibiotic for URTI and CAP. This was only implemented in the outpatient clinics and emergency department.

Education

An infectious diseases pharmacist conducted an educational session on the “Shorter is Better” initiative during a departmental meeting for outpatient clinics and emergency department. This session included physicians, nurses, and healthcare staff, ensuring comprehensive awareness and adherence to evidence-based antibiotic prescribing practices.

Statistical analysis

We analyzed categorical data using χ2 test and continuous data using the Student t test. We also utilized a multivariate logistic regression model to identify independent factors associated with the adherence to the recommended antibiotic duration. Odds ratios (ORs) and 95% confidence intervals (CI) were calculated for all associations in the logistic regression. All statistical analyses were performed using SPSS version 27.0 (IBM, USA).

Result

During the study period, a total of 2 335 patients received oral antibiotics for respiratory infections in the outpatient settings. Of these, 15 were excluded based on the exclusion criteria. We included 2 320 patients in our study, of which 1 359 were in the preintervention period and 961 in the postintervention period (Table 2).

Table 2. Characteristics of outpatients with respiratory tract infections in the pre- and postintervention periods of the multifaceted stewardship initiative

* Some patients received combination therapy.

The median age of participants was 23 years (IQR, 7–39), and 996 (43%) were male. Most patients had no significant underlying medical conditions, and 2,117 (91.5%) were diagnosed as having URTIs. Regarding antibiotic use, β-lactams were the most frequently prescribed agents (1,527; 65.8%), followed by macrolides (761; 32.8%), fluoroquinolones (25; 1.1%), and doxycycline (7; 0.3%) (Table 2).

Following implementation of the multifaceted stewardship initiative, significant improvements were observed in antibiotic prescribing metrics for RTIs. The DOT per 1,000 outpatient visits decreased from 131 to 50, indicating an overall reduction in antibiotic exposure. Similarly, the mean duration of antibiotic therapy declined from 6.3 to 6.0 days (P < 0.001). Adherence to the recommended duration also improved, with the percentage of prescriptions meeting recommended duration increasing from 54.2% to 58.8% (P = 0.02) (Table 3).

Table 3. Comparison of antibiotic prescribing metrics pre- and postintervention periods of the multifaceted stewardship initiative

In multivariate logistic regression analysis, the intervention was associated with significantly higher odds of adherence to recommended antibiotic duration (OR = 1.2, 95% CI 1.10–1.41, p = 0.036). Adults had higher odds of adherence than pediatric patients (OR = 1.01, 95% CI 1–1.01, P = 0.03). Patients who visited outpatient clinics had higher odds of adherence compared to those seen in the emergency department (OR = 1.13, 95% CI: 1.13–1.69, p = 0.001). Gender (P = .10) was not significantly associated with adherence (Table 4).

Table 4. Multivariate logistic regression identifying predictors of adherence to recommend duration

Reference categories: period = preintervention; age group = pediatrics; gender = male; location = emergency department.

Discussion

To our knowledge, this is the first study to evaluate the impact of multifaceted ASP initiative targeting antibiotic duration in the region. Our intervention, including CDS and education, was associated with improvements in key ASP metrics such as antibiotic utilization, mean antibiotic duration, and percentage of adherence to recommended duration.

Various stewardship programs have been implemented internationally to reduce unnecessary antibiotic exposure and improve patient’s outcomes. Reference Weslander, Li and Wang10,Reference Sun, Jones and Fricchione11 Some of these initiatives include clickable duration option in the EHR and automatic stop dates in the EHR. Reference Weslander, Li and Wang10,Reference Sun, Jones and Fricchione11 In our study, we used a multifaceted intervention to guide the physicians to choose the shortest effective duration, which led to a 38.2% reduction in the DOT per 1 000 visits and a 11.7% improvement in adherence to evidence-based duration. Although the mean duration of therapy decreased significantly from 6.4 to 6.0 days, this reduction is unlikely to be clinically meaningful in practice. However, this finding suggests that outpatient antibiotic prescribing practices may not alarming. Importantly, sustained implementation of ASP interventions remains essential, as even modest improvements can reinforce appropriate prescribing behaviors and contribute cumulatively to reducing unnecessary antibiotic exposure over time.

Similar outcomes in ASP metrics such as DOT reduction have been reported in other studies that implemented duration-based interventions. Reference Sun, Jones and Fricchione11Reference Lloyd, Dillman and Tribble14

In our study, the shift in antibiotic use from β-lactams to other agents in the postintervention period may reflect evolving prescribing behaviors within the emergency medicine service or emerging resistance patterns, particularly during the COVID-19 pandemic. Reference Sulayyim, Ismail, Hamid and Ghafar15

These kind of ASP efforts align with global and national initiatives to reduce AMR by minimizing unnecessary antibiotic exposure and are consistent with the Saudi Vision 2030 Health Sector Transformation Program, which prioritizes combating AMR through targeted ASPs, automation, and surveillance. 5,6,Reference Alshehri, Aldali and Abdelhamid9

These findings collectively highlight the value of multifaceted stewardship approaches, including education and automation.

Our study has several limitations. First, as a retrospective analysis of a quality improvement project, the results may be subject to residual confounding. Second, this was a single-center study, which may limit the generalizability of the findings to other hospitals in the region. Finally, because accurate diagnostic coding for RTIs was not available, we calculated DOT per 1,000 outpatient visits, which may not precisely reflect prescribing appropriateness for RTI cases.

Conclusion

In summary, we implemented a multifaceted ASP initiative—including CDS and education—to guide physicians in selecting the shortest effective antibiotic duration for RTIs in outpatient settings. This intervention can reduce unnecessary antibiotic exposure and improve the adherence to the recommended duration. This is one of the few studies of such initiatives from the Eastern Mediterranean region, which is a site of significant rise of AMR.

Acknowledgements

This research was financially supported by Princess Nourah bint Abdulrahman University Researchers Supporting Project number (PNURSP2025R336), Princess Nourah bint Abdulrahman University, Riyadh, Saudi Arabia. The authors used ChatGPT (OpenAI) for minor editing to improve clarity and grammar. No AI-generated content was used for data analysis, interpretation, or original writing. The authors are fully responsible for all content.

Author contributions

All authors contributed to the conception and design of the study. [MA], [FA], [NA], and [HA] collected and curated the data. [AA] and [EA] performed the statistical analysis. [AA], [RB], and [LA] drafted the initial manuscript. [AA], [MK], [AS], and [WA] critically revised the manuscript for important intellectual content. All authors read and approved the final version of the manuscript and agree to be accountable for all aspects of the work

Competing interests

There is no conflict of interest for all authors involved in the publication process

Disclosure

All the authors have approved the final article and declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper. The authors declare no financial conflicts of interest. The views expressed in this paper are those of the author(s) and not do not necessarily reflect those of the SFDA or its stakeholders. Guaranteeing the accuracy and the validity of the data is a sole responsibility of the research team.

Declarations

Ethical approval and consent to participate Ethical approval was obtained from the institutional review board of King Abdullah bin Abdul-Aziz University Hospital (IRB Log Number: 21–0006). The views expressed in this paper are those of the authors and do not necessarily reflect those of the SFDA or its stakeholders. The accuracy and validity of the data are the sole responsibility of the research team.

References

World Health Organization. Antimicrobial resistance. 2023. https://www.who.int/news-room/fact-sheets/detail/antimicrobial-resistance. Accessed August 5, 2025.Google Scholar
Antimicrobial Resistance Collaborators. Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis. Lancet 2022;399:629655.10.1016/S0140-6736(21)02724-0CrossRefGoogle Scholar
Kiran, MA, Alghamdi, S, Ashgar, S, Alhindi, Z, Al-Abdullah, N, Dablool, AS. Systematic review and meta-analysis on antimicrobial resistance and drug resistance in Saudi Arabia. J Glob Antimicrob Resist 2024;39:128136.10.1016/j.jgar.2024.07.013CrossRefGoogle ScholarPubMed
Almakrami, M, Salmen, M, Aldashel, YA, et al. Prevalence of multidrug-, extensively drug-, and pandrug-resistant bacteria in clinical isolates from King Khaled hospital, Najran, Saudi Arabia. Discov Med 2024;1:108.10.1007/s44337-024-00094-8CrossRefGoogle Scholar
Ministry of Health (Kingdom of Saudi Arabia). Kingdom of Saudi Arabia: Second Antimicrobial Resistance Action Plan 2020–2025. World Health Organization; 2020.Google Scholar
Ministry of Health (Saudi Arabia). Saudi Arabia continues national efforts to combat antimicrobial resistance. 2024. https://www.moh.gov.sa/en/Ministry/MediaCenter/News/Pages/News-2024-11-16-001.aspx.Google Scholar
Wald-Dickler, N, Spellberg, B. Short-course antibiotic therapy – Replacing constantine units with “shorter Is better.”. Clin Infect Dis 2019;69:14761479.10.1093/cid/ciy1134CrossRefGoogle ScholarPubMed
Moussaoui, RE, De Borgie, CAJM, Van Den Broek, P, et al. Effectiveness of discontinuing antibiotic treatment after three days versus eight days in mild to moderate-severe community acquired pneumonia: randomised, double blind study. BMJ 2006;332:1355.10.1136/bmj.332.7554.1355CrossRefGoogle ScholarPubMed
Alshehri, A, Aldali, J, Abdelhamid, M, et al. Implementation of antimicrobial stewardship programs in Saudi Arabia: a systematic review. Microorganisms 2025;13:440.10.3390/microorganisms13020440CrossRefGoogle ScholarPubMed
Weslander, E, Li, D, Wang, X. 64. Impact of a duration bundle on antimicrobial use in a pediatric hospital. Open Forum Infect Dis 2020;7:S52S52.10.1093/ofid/ofaa439.109CrossRefGoogle Scholar
Sun, S, Jones, RC, Fricchione, MJ, et al. Short-duration electronic health record option buttons to reduce prolonged length of antibiotic therapy in outpatients. Pediatrics 2021;147:e2020034819.10.1542/peds.2020-034819CrossRefGoogle ScholarPubMed
Heo, E, Lee, Y, Kim, HS, et al. P-1775. Impact of a stewardship intervention targeting prolonged antibiotic use ( >15 Days) on antibiotic utilization, resistance patterns, and costs. Open Forum Infect Dis 2025;12ofae631.1938.10.1093/ofid/ofae631.1938CrossRefGoogle Scholar
Gerhardt, J, Cheatham, M, Davis, CM, et al. 921. Leveraging the electronic health record for antimicrobial stewardship: assessing the impact of antimicrobial ordering clinical decision support tools on duration of therapy. Open Forum Infect Dis 2022;9:ofac492.766.10.1093/ofid/ofac492.766CrossRefGoogle Scholar
Lloyd, EC, Dillman, NO, Tribble, AC, et al. Electronic medical record-embedded clinical decision support decreases inappropriate duration of antibiotics for outpatient pediatric skin and soft tissue infections. Open Forum Infect Dis 2022;9:ofac492.1376.10.1093/ofid/ofac492.1376CrossRefGoogle Scholar
Sulayyim, HJA, Ismail, R, Hamid, AA, Ghafar, NA. Antibiotic resistance during COVID-19: a systematic review. IJERPH 2022;19:11931.10.3390/ijerph191911931CrossRefGoogle ScholarPubMed
Figure 0

Table 1. Institutional antimicrobial stewardship guidelines on recommended duration of oral antibiotic therapy for respiratory infections in outpatient settings

Figure 1

Table 2. Characteristics of outpatients with respiratory tract infections in the pre- and postintervention periods of the multifaceted stewardship initiative

Figure 2

Table 3. Comparison of antibiotic prescribing metrics pre- and postintervention periods of the multifaceted stewardship initiative

Figure 3

Table 4. Multivariate logistic regression identifying predictors of adherence to recommend duration